Fertility and Sterility
Volume 92, Issue 2 , Pages 828.e1-828.e2, August 2009

Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist

Racine In Vitro Fertilization Unit, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Received 21 February 2009; received in revised form 10 April 2009; accepted 27 April 2009. published online 15 June 2009.

Objective

To describe isolation and in vitro maturation of primary oocytes from the ovarian cortex in the presence of hypothalamic pituitary down-regulation.

Design

Case report.

Setting

Tertiary care university-affiliated hospital.

Patient(s)

An 18-year-old patient was given treatment with the ABVD (Adriamycin, bleomycin, vinblastine, and dacarbazine) protocol for Hodgkin's disease. She underwent ovarian tissue cryopreservation while being cotreated with GnRH agonist because of disease relapse.

Intervention(s)

Laparoscopic oophorectomy, ovarian tissue cryopreservation, and in vitro maturation of primary oocytes.

Main Outcome Measure(s)

Maturation of primary oocytes isolated from the medium used for preparation of ovarian tissue.

Result(s)

Twenty-one immature germinal vesicle–stage oocytes were isolated from the medium of dissection. All were incubated in in vitro maturation medium, and five were maturated and frozen.

Conclusion(s)

The fact that germinal vesicle–stage oocytes were present in our patient's medium despite hormonal down-regulation demonstrates that GnRH agonist does not completely inhibit antral follicle development.

Key Words: GnRH-agonist, in vitro maturation, fertility preservation, Hodgkin's disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 F.A. has nothing to disclose. J.H. has nothing to disclose. T.C. has nothing to disclose. T.S. has nothing to disclose. N.M.-R. has nothing to disclose. B.A. has nothing to disclose. A.A. has nothing to disclose. D.B.-Y. has nothing to disclose.

PII: S0015-0282(09)01077-2

doi:10.1016/j.fertnstert.2009.04.052

Fertility and Sterility
Volume 92, Issue 2 , Pages 828.e1-828.e2, August 2009